- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03981250
Effect of One Minute of Resistance Exercise Per Day on Muscular Strength (The ONE Study)
The ONE Study: Effect of One Minute of Resistance Exercise Per Day on Muscular Strength
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A resistance training programme can lead to a variety of health benefits including increases in muscle size and strength. Other potential health benefits of resistance training include reduction of body fat, increased metabolic rate, improve insulin sensitivity, blood glucose tolerance and blood lipid profiles. Meta-analyses indicate that while performing resistance exercise two or more times per week of resistance exercise per muscle group appears to be optimal to maximise strength gains, a single set of resistance exercise per muscle group per week, if performed to failure is sufficient to induce substantial strength changes.
The current physical activity guidelines recommend undertaking muscle strengthening activities involving major muscle groups two days a week or more, as well as undertaking at least 150 minutes per week of moderate intensity physical activity (or 75 minutes per week of vigorous intensity physical activity). However, only small portion of the population achieves the muscle strengthening aspect of the guidelines. As lack of time is often cited as a reason not to engage in physical activity, this study is seeking to investigate a low time-commitment approach to resistance exercise which could increase muscular strength. To address this, the present study will to split a typical single session of resistance exercise involving several exercises across different muscle groups into separate 1-minute micro-sessions where a different muscle group is exercised on each day of the week. The aim is to determine the effects of a one-minute-per-day home-based resistance exercise training on muscular strength.
The study is a randomized control trial in which the control group will continue their lifestyle behaviour and will be asked not to increase their physical activity levels and the exercise group will perform a 12-week home-based resistance exercise programme, involving doing one minute of resistance exercise per day on six days of the week, with a different exercise performed on each day. All participants will be measured at baseline, 4 weeks, 8 weeks and 12 weeks.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Glasgow, United Kingdom, G12 8TA
- University of Glasgow
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged 18-65 years
Exclusion Criteria:
- Diabetes
- Uncontrolled hypertension (blood pressure > 150/90 on medication).
- History of cardiovascular disease
- Undertaking more than 150 minutes of moderate intensity or 75 minutes of vigorous physical activity or undertaking any resistance exercise.
- Other significant illness that would prevent the participant to undertake physical activity.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: Control Group
The control group will be asked to keep their lifestyle behaviour and not increase their physical activity levels during the study period.
|
|
|
EXPERIMENTAL: Exercise Group
The exercise group will engage in a home-based resistance exercise intervention for 12 weeks.
They will perform 6 exercises, one each day for one minute, for 6 days a week.
|
Participants will perform 6 exercises (press-ups, squats, squat jumps, plank, upright row and seated row) for one minute, aiming for the maximum number of repetitions.
Participants will perform one exercise per day, for 6 days a week, for 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle strength
Time Frame: Change between baseline and 4 weeks
|
Change in 1-RM (one repetition maximum) (kg) for bench press, leg press and lat pull down (kg).
|
Change between baseline and 4 weeks
|
|
Muscle strength
Time Frame: Change between baseline and 8 weeks
|
Change in 1-RM (one repetition maximum) (kg) for bench press, leg press and lat pull down (kg).
|
Change between baseline and 8 weeks
|
|
Muscle strength
Time Frame: Change between baseline and 12 weeks
|
Change in 1-RM (one repetition maximum) (kg) for bench press, leg press and lat pull down (kg).
|
Change between baseline and 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle endurance
Time Frame: Change between baseline and 4 weeks
|
Change in maximal number of repetitions with a load of 50% of baseline 1-RM for bench press, leg press and lateral pull down.
|
Change between baseline and 4 weeks
|
|
Muscle endurance
Time Frame: Change between baseline and 8 weeks
|
Change in maximal number of repetitions with a load of 50% of baseline 1-RM for bench press, leg press and lateral pull down.
|
Change between baseline and 8 weeks
|
|
Muscle endurance
Time Frame: Change between baseline and 12 weeks
|
Change in maximal number of repetitions with a load of 50% of baseline 1-RM for bench press, leg press and lateral pull down.
|
Change between baseline and 12 weeks
|
|
Weight
Time Frame: Change between baseline and 4 weeks
|
Change in weight (kg).
|
Change between baseline and 4 weeks
|
|
Weight
Time Frame: Change between baseline and 8 weeks
|
Change in weight (kg).
|
Change between baseline and 8 weeks
|
|
Weight
Time Frame: Change between baseline and 12 weeks
|
Change in weight (kg).
|
Change between baseline and 12 weeks
|
|
Waist
Time Frame: Change between baseline and 4 weeks
|
Change in waist circumference (cm).
|
Change between baseline and 4 weeks
|
|
Waist
Time Frame: Change between baseline and 8 weeks
|
Change in waist circumference (cm).
|
Change between baseline and 8 weeks
|
|
Waist
Time Frame: Change between baseline and 12 weeks
|
Change in waist circumference (cm).
|
Change between baseline and 12 weeks
|
|
Body composition
Time Frame: Change between baseline and 4 weeks
|
Change in fat mass and free fat mass measured by Bioelectrical Impedance Analysis (BIA).
|
Change between baseline and 4 weeks
|
|
Body composition
Time Frame: Change between baseline and 8 weeks
|
Change in fat mass and free fat mass measured by Bioelectrical Impedance Analysis (BIA).
|
Change between baseline and 8 weeks
|
|
Body composition
Time Frame: Change between baseline and 12 weeks
|
Change in fat mass and free fat mass measured by Bioelectrical Impedance Analysis (BIA).
|
Change between baseline and 12 weeks
|
|
Muscle thickness
Time Frame: Change between baseline and 12 weeks
|
Change in muscle thickness of vastus lateralis (mm) measured with ultrasound.
|
Change between baseline and 12 weeks
|
|
Grip strength
Time Frame: Change between baseline and 4 weeks
|
Change in grip strength (kg) measured using a hand grip dynamometer
|
Change between baseline and 4 weeks
|
|
Grip strength
Time Frame: Change between baseline and 8 weeks
|
Change in grip strength (kg) measured using a hand grip dynamometer
|
Change between baseline and 8 weeks
|
|
Grip strength
Time Frame: Change between baseline and 12 weeks
|
Change in grip strength (kg) measured using a hand grip dynamometer
|
Change between baseline and 12 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 200180137
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.